Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ferrari

Showing results (21-30 of 1,032) with videos related to

Pageof 104
Sort By:
Praxis|January 8, 2004
[Therapy of hypertension in kidney diseases]P Ferrari, O Bonny
Minerva Medica|October 10, 1973
[Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370]A Scanni, P Ferrari
Therapeutische Umschau. Revue Therapeutique|October 21, 2004
[Diagnosis and prevention of uric acid stones]P Ferrari, O Bonny
Radiation Protection Dosimetry|June 16, 2007
MCNPX internal dosimetry studies based on the NORMAN-05 voxel modelP Ferrari, G Gualdrini
Radiation Protection Dosimetry|June 8, 2007
Monte Carlo evaluated parameters for internal dosimetryG Gualdrini, P Ferrari
Radiation Protection Dosimetry|November 18, 2006
Fluence to organ dose conversion coefficients calculated with the voxel model NORMAN-05 and the MCNPX Monte Carlo code for external monoenergetic photons from 20 keV to 100 MeVP Ferrari, G Gualdrini
Journal of Hypertension|June 1, 1990
Insulin, insulin sensitivity and hypertensionP Ferrari, P Weidmann
Clinical and Experimental Pharmacology & Physiology|December 1, 1995
A genetic approach to the pathogenesis of primary hypertension and to its treatmentG Bianchi, P Ferrari
Drugs|June 14, 2000
The genomics of cardiovascular disorders: therapeutic implicationsP Ferrari, G Bianchi
Mineral and Electrolyte Metabolism|January 1, 1990
Insulin sensitivity in humans: alterations during drug administration and in essential hypertensionP Ferrari, P Weidmann
Pageof 104

Showing results (21-30 of 1,032) with videos related to

Sort By:
Pageof 104
Praxis|January 8, 2004
[Therapy of hypertension in kidney diseases]P Ferrari, O Bonny
Minerva Medica|October 10, 1973
[Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370]A Scanni, P Ferrari
Therapeutische Umschau. Revue Therapeutique|October 21, 2004
[Diagnosis and prevention of uric acid stones]P Ferrari, O Bonny
Radiation Protection Dosimetry|June 16, 2007
MCNPX internal dosimetry studies based on the NORMAN-05 voxel modelP Ferrari, G Gualdrini
Radiation Protection Dosimetry|June 8, 2007
Monte Carlo evaluated parameters for internal dosimetryG Gualdrini, P Ferrari
Radiation Protection Dosimetry|November 18, 2006
Fluence to organ dose conversion coefficients calculated with the voxel model NORMAN-05 and the MCNPX Monte Carlo code for external monoenergetic photons from 20 keV to 100 MeVP Ferrari, G Gualdrini
Journal of Hypertension|June 1, 1990
Insulin, insulin sensitivity and hypertensionP Ferrari, P Weidmann
Clinical and Experimental Pharmacology & Physiology|December 1, 1995
A genetic approach to the pathogenesis of primary hypertension and to its treatmentG Bianchi, P Ferrari
Drugs|June 14, 2000
The genomics of cardiovascular disorders: therapeutic implicationsP Ferrari, G Bianchi
Mineral and Electrolyte Metabolism|January 1, 1990
Insulin sensitivity in humans: alterations during drug administration and in essential hypertensionP Ferrari, P Weidmann
Pageof 104